Table 1.
Heterogeneity of CD8+ Tregs.
Phenotype | Features | Ways to acquire | Source | Effect in GVHD | Ref. |
---|---|---|---|---|---|
CD8+CD25+Foxp3+ | Expressing CTLA-4, TNFR2 and other various surface makers for different situations such as GITR, CD44, CD102 and CD133, dependent on IL-2 and TGF-β for phenotype and function | Naturally occurring and induced | Humans and Mice | Yes | (25, 26, 28, 29, 31, 33, 39, 49–51) |
CD8+CD103+ | CD103 may compensate the deficiency of Foxp3 in regulating immune response, and dependent on IL-2 and TGF-β and is more stable than CD4+Tregs to some extent. | Induced | Humans and Mice | Yes | (40–42, 52, 53) |
CD8hi Tregs | Antigen-specific and expressing CD25, Foxp3 and CTLA-4 extremely similar to CD8+CD25+Foxp3+ Tregs | Induced | Humans | Yes | (30, 34, 54) |
CD8+CD45RClow/- | Expressing foxp3 and dependent on production of IL-10 and TGF-β | Naturally occurring and induced | Humans and Rats | Yes | (16, 55) |
CD8+CD28-/low | Less dependent on Foxp3 for immunoregulatory properties, and other molecules may be highly relevant | CD8+CD28low Tregs are more likely to occur naturally, and CD8+CD28- Tregs tend to be induced | Humans and Mice | not described | (56–59) |
CD8+CD122+ | Dependent on PD-1 and CD28 but not Foxp3, which is related to recognition of CD80/86 and production of IL-10; sometimes more powerful than CD4+ Tregs | Induced | Mice (human CD8+CXCR3+ Tregs may be the counterparts of mice CD8+CD122+ Tregs) | not described | (60–66) |